Drug
Nonacog Beta Pegol
Nonacog Beta Pegol: highest development phase Phase 1, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| nonacog beta pegol NCT00956345 | Phase 1 | Congenital Bleeding Disorder |
Latest
No recent events.
Follow Nonacog Beta Pegol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.